Origin Therapeutics Holdings (XCNQ:ORIG) Revenue : C$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Revenue?

Origin Therapeutics Holdings's revenue for the three months ended in Jun. 2023 was C$0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil. Origin Therapeutics Holdings's Revenue per Share for the three months ended in Jun. 2023 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Origin Therapeutics Holdings Revenue Historical Data

The historical data trend for Origin Therapeutics Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Revenue Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Revenue

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Revenue	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Revenue falls into.

Origin Therapeutics Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Origin Therapeutics Holdings (XCNQ:ORIG) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Origin Therapeutics Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.